Loading...
Loading...
Loading...
Loading...
Leptin Antagonist Quadruple Mutant, Human Recombinant
| Size | 50 µg, 1000 µg |
| Estimated Lead Time | 2-3 weeks |
| Species | Human |
| Expressed Region | The sequence of the first five N-terminal amino acids was determined and was found to be Ala-Val-Pro-Ile-Gln. |
| Expression System | E. coli |
| Purity | Greater than 98.0% as determined by:(a) Gel filtration analysis.(b) Analysis by SDS-PAGE. |
| Format | White lyophilized (freeze-dried) powder. |
| Formulation | The protein was lyophilized from a concentrated (1mg/ml) solution with 0.0045mM NaHCO3. |
| Activity | RayBiotech's Leptin Quadruple Antagonist Mutant is capable of inhibiting leptin-induced proliferation of BAF/3 cells stably transected with the long form of human Leptin receptor. It also inhibits various Leptin effects in several in vitro bioassays. |
| Research Area | Energy Metabolism, Obesity & Metabolic Disease |
| Shipping Type | Ambient temperature |
| Storage | -20°C |
Your cart is empty.
Leptin Antagonist Quadruple Mutant, Human Recombinant